LEADER 01914oam  2200457   450 
001 9910705227903321
005 20140730122759.0
035   $a(CKB)5470000002449090
035   $a(OCoLC)876288856
035   $a(EXLCZ)995470000002449090
100   $a20140410d2014      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aSecuring the pharmaceutical supply chain $ehearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session, on examining securing the pharmaceutical supply chain, focusing on how the Food and Drug Administration faces challenges overseeing the foreign drug manufacturing supply chain, September 14, 2011
210  1$aWashington :$cU.S. Government Printing Office,$d2014.
215   $a1 online resource (iii, 90 pages) $cillustration
225 1 $aS. hrg. ;$v112-866
300   $aTitle from title screen (viewed on Apr. 10, 2014).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
320   $aIncludes bibliographical references.
517   $aSecuring the pharmaceutical supply chain 
606   $aPharmaceutical industry$xSecurity measures$zUnited States
606   $aProduct counterfeiting$zUnited States$xPrevention
606   $aDrug adulteration$zUnited States$xPrevention
608   $aLegislative hearings.$2lcgft
615  0$aPharmaceutical industry$xSecurity measures
615  0$aProduct counterfeiting$xPrevention.
615  0$aDrug adulteration$xPrevention.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bCOO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910705227903321
996   $aSecuring the pharmaceutical supply chain$93527359
997   $aUNINA